Consultants of the year – transactional

EY-Parthenon

EY-Parthenon is a fast-growing strategy consultancy, committed to bringing unconventional yet pragmatic thinking to deliver actionable strategies with real impact. With more than 1,500 consultants globally, EY-Parthenon has grown rapidly over the past five years. With healthcare practices in the UK, US, MENA and Asia-Pacific, EY-Parthenon offers global perspectives. The company represents a central pillar of EY’s transaction advisory services proposition, through which EY offers end-to-end connected capital solutions across the transaction life cycle. EY transaction advisory services offers lead advisory, valuations, transaction diligence, strategy and commercial diligence, restructuring, and tax services, providing a comprehensive proposition to unlock the greatest value for clients.

PwC

PwC has a dedicated health services, medtech and pharma deal team of more than 100 people across the UK. It supports clients in the private and public sector healthcare spaces, leveraging its wealth of experience to provide robust, evidenced and realisable views on key questions and areas of focus. PwC works with clients, both operators and investors, across all the key healthcare subsectors and supports on acquisitions, divestments, raising finance, developing strategy, embedding operational, regulatory and quality excellence, driving management reporting solutions, and data analytics.

ADVISORY & FINANCE

Consultants of the year – transactional

Candesic

CIL Management Consultants

Connell Consulting

EY-Parthenon

PwC

Clearwater International

Clearwater International is a corporate finance house with a proven track record of excellent client outcomes – more than 95% of its clients would have no hesitation in recommending the business. With 17 offices around the world, the company’s 250-plus experienced professionals have been responsible for the completion of over 1,690 deals worth in excess of €91 billion. Clearwater International’s dedicated healthcare team has completed 107 transactions with a combined value of around €10.7 billion. The team is currently working on several projects in the health and social care, medical devices, and pharmaceutical markets.

Deloitte

Deloitte is the largest professional services firm in the world, with a global network of 286,000 professionals providing audit, tax, consulting and financial advisory services. Deloitte’s life sciences and healthcare M&A practice topped the 2019 Mergermarket league tables by deal volume globally and in the past three years completed 150 deals worth over £6 billion. Deloitte is one of the most active mid-market life sciences and healthcare M&A advisors in the UK. It works closely with pharmaceutical, healthcare services and medtech corporates, as well as private equity houses and owner-managers, on buy/ sell-side transactions, joint ventures and public/private partnerships.

KPMG UK

KPMG is a multinational professional services network supporting clients globally and one of its dedicated sectors is UK healthcare corporate finance. KPMG UK’s healthcare corporate finance team has more than 200 professionals working across the public and private health and care systems. This team is connected to KPMG’s wider global health network of over 2,000 practitioners led by Dr Mark Britnell, KPMG’s global chairman for healthcare, government and infrastructure. KPMG works with central and local governments, the Care Quality Commission, regulators, and public and private sector partners, to support them in rising to the challenges affecting healthcare systems.